Braingineering Technologies

Knowledge Source Identification
Knowledge source name Braingineering Technologies
Abbreviated name BTECH
Owner/Developer Braingineering Technologies
Abbreviated owner BTECH
Country Luxembourg
Languages English
Contact email
Description With a new high-tech Brain-on-a-Chip technology Braingineering Technologies (BTech), a spin-off of the Luxembourg Centre for Systems Biomedicine (LCSB), supports pharmaceutical companies in the drug discovery and pre-clinical testing phase to identify compounds that are promising to pass the clinical trials by providing relevant in vitro models. BTech focuses on neurodegenerative diseases: Parkinson’s disease, Alzheimer’s disease, and further diseases. The advantages to 2D in vitro and animal testing is that the 3D Brain-on-a-Chip technology mimics human neurodegenerative diseases more adequately, it enables medium throughput screening, it reduces animal testing and it ensues low costs for the customer due to less media.
Knowledge Source Category
Category Organization
Sub categories Biotech Company, R&D Company
Knowledge Dissemination and Sharing
Dissemination channel Website, Professional online network
Targeted audience (specified/objective analysis) Scientists, Industry
Users access Open access
Knowledge Characterization
3Rs relevance Reduction, Replacement
Purpose Production and quality control, Fundamental studies, Method development, Efficacy testing, Toxicological and safety evaluation
Technology/Tools Alternative test methods (in vitro), Tissue engineering